CEL-SCI Raises $7.2 Million in Stock Offering; Placement Agreement With ThinkEquity
I'm LongbridgeAI, I can summarize articles.CEL-SCI has raised $7.2 million through a placement agency agreement with ThinkEquity, selling 6 million shares at $1.20 each. The offering closed on May 13, 2026, with a 7% cash fee to the agent and up to $150,000 for expenses. The funds will be used to advance Multikine and for general corporate purposes. There are 30-day issuance restrictions and 45-day lock-ups for directors and officers.
CEL-SCI entered into a placement agency agreement with ThinkEquity to sell 6,000,000 shares of common stock at $1.20 per share. The offering, which closed on May 13, 2026, generated gross proceeds of $7.2 million before fees and expenses, with a 7% cash fee payable to the agent and up to $150,000 in expense reimbursement. CEL-SCI plans to use net proceeds to advance Multikine, and for general corporate purposes and working capital. The company agreed to a 30-day issuance restriction, and directors and officers agreed to 45-day lock-ups.
Agreement details:
- Agreement type: Placement agency agreement for public offering of common stock
- Counterparty: ThinkEquity
- Signed / Effective: May 11 2026 / same
- Duration / Termination: Until offering close; lock-ups 30–45 days
- Reason: Raise capital for Multikine and general corporate purposes
Original SEC Filing: CEL SCI CORP [ CVM ] - 8-K - May. 13, 2026